Translational Drug Development for Pediatric CNS Disorders
Publication
, Conference
Potter, W; Grabb, M; Pandina, G; Jeste, S; Di Martino, A; Gur, R; Hornik, C; Mantua, V; Taylor-Zapata, P; Umbricht, D
Published in: NEUROPSYCHOPHARMACOLOGY
2021
Duke Scholars
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
2021
Volume
46
Issue
SUPPL 1
Start / End Page
6 / 6
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Potter, W., Grabb, M., Pandina, G., Jeste, S., Di Martino, A., Gur, R., … Umbricht, D. (2021). Translational Drug Development for Pediatric CNS Disorders. In NEUROPSYCHOPHARMACOLOGY (Vol. 46, pp. 6–6).
Potter, William, Meg Grabb, Gahan Pandina, Shafali Jeste, Adriana Di Martino, Raquel Gur, Christoph Hornik, Valentina Mantua, Perdita Taylor-Zapata, and Daniel Umbricht. “Translational Drug Development for Pediatric CNS Disorders.” In NEUROPSYCHOPHARMACOLOGY, 46:6–6, 2021.
Potter W, Grabb M, Pandina G, Jeste S, Di Martino A, Gur R, et al. Translational Drug Development for Pediatric CNS Disorders. In: NEUROPSYCHOPHARMACOLOGY. 2021. p. 6–6.
Potter, William, et al. “Translational Drug Development for Pediatric CNS Disorders.” NEUROPSYCHOPHARMACOLOGY, vol. 46, no. SUPPL 1, 2021, pp. 6–6.
Potter W, Grabb M, Pandina G, Jeste S, Di Martino A, Gur R, Hornik C, Mantua V, Taylor-Zapata P, Umbricht D. Translational Drug Development for Pediatric CNS Disorders. NEUROPSYCHOPHARMACOLOGY. 2021. p. 6–6.
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
2021
Volume
46
Issue
SUPPL 1
Start / End Page
6 / 6
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences